Three out of five GPs in Asia Pacific would be willing to forego at least 5% of near-term profit if that sum could be invested in making their portfolio companies more resilient across a range of metrics.
The finding, part of a survey that accompanies Bain & Company’s latest Asia Pacific private equity report, underlines the extent of the portfolio-level damage caused by COVID-19 and the expectation of...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.
Northleaf Capital Partners, a Canada-based asset manager that invests in private equity, private credit, and infrastructure, has opened a Tokyo office to spearhead fundraising activity in Asia and is considering the addition of a Korea presence.